GS Pharmaceutical Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A1

  • Investors
  • 3

GS Pharmaceutical General Information

Description

Developer and provider of photodynamic therapy services intended to serve the healthcare industry. The company is mainly focused on the research and development of photodynamic products including Innovative photosensitizers and related drugs, providing clients with industry-leading standard drugs and treatments.

Contact Information

Website
www.shgsmed.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 404, Block B, Building 1, No. 800, Qingdai Road
  • Zhoupu, Pudong New Area
  • Shanghai, 201318
  • China
+86 021
Primary Industry
Therapeutic Devices
Other Industries
Pharmaceuticals
Hospitals/Inpatient Services
Vertical(s)
Corporate Office
  • Room 404, Block B, Building 1, No. 800, Qingdai Road
  • Zhoupu, Pudong New Area
  • Shanghai, 201318
  • China
+86 021

GS Pharmaceutical Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GS Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A1) 26-Nov-2024 Completed Generating Revenue
1. Later Stage VC (Series A) 26-Feb-2024 Completed Generating Revenue
To view GS Pharmaceutical’s complete valuation and funding history, request access »

GS Pharmaceutical Patents

GS Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260069696-A1 Combined therapy of photodynamic therapy and immune checkpoint inhibitor Pending 19-May-2023

GS Pharmaceutical Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Shanghai Science & Technology Investment Venture Capital Minority
Shanghai Zhangjiang Science & Technology Venture Capital Venture Capital Minority
Oriental Fortune Capital Venture Capital Minority
To view GS Pharmaceutical’s complete investors history, request access »

GS Pharmaceutical FAQs

  • When was GS Pharmaceutical founded?

    GS Pharmaceutical was founded in 2018.

  • Where is GS Pharmaceutical headquartered?

    GS Pharmaceutical is headquartered in Shanghai, China.

  • What industry is GS Pharmaceutical in?

    GS Pharmaceutical’s primary industry is Therapeutic Devices.

  • Is GS Pharmaceutical a private or public company?

    GS Pharmaceutical is a Private company.

  • What is GS Pharmaceutical’s current revenue?

    The current revenue for GS Pharmaceutical is .

  • How much funding has GS Pharmaceutical raised over time?

    GS Pharmaceutical has raised $14M.

  • Who are GS Pharmaceutical’s investors?

    Shanghai Science & Technology Investment, Shanghai Zhangjiang Science & Technology Venture Capital, and Oriental Fortune Capital have invested in GS Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process